|
Saturday, April 13 |
|
06:45-08:15 |
|
| |
Hall A
Multiple Sclerosis |
Hall B
Dementia |
Hall C
Epilepsy |
Hall D
Dystonia / Rehabilitation |
|
08:30-10:30 |
Session 13:
Outcome Measures in MS Clinical Studies; Origin of MS: Imflammatory or degenerative? Genetic or environmental?
Partially supported by an unrestricted grant from Merck Serono |
Partially supported by an unrestricted grant from Elan Pharmaceuticals |
|
Session 25:
Treatment of Dystonia
|
|
10:30-11:00 |
Coffee Break, Poster Viewing and Exhibition |
|
11:00-13:30 |
|
Session 18:
Can the Natural History of Dementia be Modified
Partially supported by an unrestricted grant from Ana Aslan |
Session 22:
Classical Questions of Epilepsy Management in the Modern Era |
|
|
Biogen Idec Symposium
(13:00-13:45) |
|
13:30-14:30 |
Lunch Break |
|
14:30-16:30 |
Partially supported by an unrestricted grant from Novartis |
Supported by an unrestricted grant from Janssen |
Session 23:
Management of Special Patients with Epilepsy |
|
|
16:30-17:00 |
Coffee Break and Exhibition |
|
17:00-18:30 |
Can the Natural History of MS be Modified?
(ends at 19:00) |
|
Session 24:
Problems of Anti-Epileptic Drug Treatment |
|
